Drug Delivery: Injection Devices

Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is regarded as one of the most accurate, effective, reliable, and reproducible methods of therapeutic drug and fluid delivery. Combined sales of injection devices (including syringes and vascular access devices, or VADs) were estimated at $4.8bn, with safety needles and syringes accounting for nearly half of sales. Over the forecast period, total sales are expected to increase at a CAGR of 6.1%, with safety syringes experiencing near double-digit growth and standard syringe sales declining at nearly 6%. The largest driver of the injection devices market is legislative changes requiring the use of safety devices to help prevent needlestick injury. Other growth factors include an increase in the number of outpatient infusion procedures involving the use of long-term VAD placement. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global syringes market (including standard and safety syringes) and VADs market (including short peripheral, midline, PICC, and central venous catheters, as well as implantable ports) for the US, five major EU markets, Japan, and RoW markets for 2018-23.